Literature DB >> 35050690

Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity.

Milka Koupenova1, Alison C Livada2,3, Craig N Morrell2,4,3,5.   

Abstract

Classically, platelets have been described as the cellular blood component that mediates hemostasis and thrombosis. This important platelet function has received significant research attention for >150 years. The immune cell functions of platelets are much less appreciated. Platelets interact with and activate cells of all branches of immunity in response to pathogen exposures and infection, as well as in response to sterile tissue injury. In this review, we focus on innate immune mechanisms of platelet activation, platelet interactions with innate immune cells, as well as the intersection of platelets and adaptive immunity. The immune potential of platelets is dependent in part on their megakaryocyte precursor providing them with the molecular composition to be first responders and immune sentinels in initiating and orchestrating coordinated pathogen immune responses. There is emerging evidence that extramedullary megakaryocytes may be immune differentiated compared with bone marrow megakaryocytes, but the physiological relevance of immunophenotypic differences are just beginning to be explored. These concepts are also discussed in this review. The immune functions of the megakaryocyte/platelet lineage have likely evolved to coordinate the need to repair a vascular breach with the simultaneous need to induce an immune response that may limit pathogen invasion once the blood is exposed to an external environment.

Entities:  

Keywords:  blood platelets; complement system proteins; extracellular traps; immunity; megakaryocyte; thrombosis; toll-like receptors

Mesh:

Year:  2022        PMID: 35050690      PMCID: PMC8852355          DOI: 10.1161/CIRCRESAHA.121.319821

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  171 in total

1.  Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.

Authors:  Hiroyuki Tada; Setsuya Aiba; Ken-Ichiro Shibata; Toshiaki Ohteki; Haruhiko Takada
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Anaphylatoxin Receptor C3aR Contributes to Platelet Function, Thrombus Formation and In Vivo Haemostasis.

Authors:  Reinhard J Sauter; Manuela Sauter; Marcus Obrich; Frederic N Emschermann; Henry Nording; Johannes Patzelt; Hans Peter Wendel; Jan-Christian Reil; Frank Edlich; Harald F Langer
Journal:  Thromb Haemost       Date:  2018-12-31       Impact factor: 5.249

3.  Platelet FcgammaRIIA binds and internalizes IgG-containing complexes.

Authors:  Randall G Worth; Christopher D Chien; Paul Chien; Michael P Reilly; Steven E McKenzie; Alan D Schreiber
Journal:  Exp Hematol       Date:  2006-11       Impact factor: 3.084

4.  Regulatory effects of TLR2 on megakaryocytic cell function.

Authors:  Lea M Beaulieu; Elaine Lin; Kristine M Morin; Kahraman Tanriverdi; Jane E Freedman
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

5.  Extracellular DNA traps promote thrombosis.

Authors:  Tobias A Fuchs; Alexander Brill; Daniel Duerschmied; Daphne Schatzberg; Marc Monestier; Daniel D Myers; Shirley K Wrobleski; Thomas W Wakefield; John H Hartwig; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 6.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

7.  Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.

Authors:  Hind Hamzeh-Cognasse; Fabrice Cognasse; Sabine Palle; Patricia Chavarin; Thomas Olivier; Olivier Delézay; Bruno Pozzetto; Olivier Garraud
Journal:  BMC Immunol       Date:  2008-09-25       Impact factor: 3.615

Review 8.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

9.  Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis.

Authors:  Claire K Meikle; Adam J Meisler; Cara M Bird; Joseph A Jeffries; Nabila Azeem; Priyanka Garg; Erin L Crawford; Clare A Kelly; Tess Z Gao; Leah M Wuescher; James C Willey; Randall G Worth
Journal:  PLoS One       Date:  2020-08-10       Impact factor: 3.240

10.  TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.

Authors:  Min Zheng; Rajendra Karki; Evan Peter Williams; Dong Yang; Elizabeth Fitzpatrick; Peter Vogel; Colleen Beth Jonsson; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-05-07       Impact factor: 25.606

View more
  5 in total

Review 1.  Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.

Authors:  Francesco Violi; Vittoria Cammisotto; Simona Bartimoccia; Pasquale Pignatelli; Roberto Carnevale; Cristina Nocella
Journal:  Nat Rev Cardiol       Date:  2022-07-15       Impact factor: 49.421

2.  Shining a light on platelet activation in COVID-19.

Authors:  Frederik Denorme; Abigail Ajanel; Robert A Campbell
Journal:  J Thromb Haemost       Date:  2022-03-02       Impact factor: 16.036

Review 3.  Sex differences at the platelet-vascular interface.

Authors:  Annamaria Sabetta; Ludovica Lombardi; Lucia Stefanini
Journal:  Intern Emerg Med       Date:  2022-05-16       Impact factor: 5.472

4.  The Neuroimmune Response to Surgery - An Exploratory Study of Trauma-Induced Changes in Innate Immunity and Heart Rate Variability.

Authors:  Malin Hildenborg; Jessica Kåhlin; Fredrik Granath; Anna Schening; Anna Granström; Anette Ebberyd; Lena Klevenvall; Henrik Zetterberg; Jinming Han; Todd T Schlegel; Robert Harris; Helena Erlandsson Harris; Lars I Eriksson
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

5.  Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.

Authors:  Yuan Shu; Jie Peng; Zuxi Feng; Kaibo Hu; Ting Li; Peijun Zhu; Tao Cheng; Liang Hao
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.